Clindamycin HCl 300mg

CLINDAMYCIN HCL Ritemed 300 milligrams



Brand Name: Ritemed
Dosage Strength: 300 milligrams
Dosage Form: Capsule


For the treatment of the following infections caused by susceptible microorganisms:

  • Upper respiratory tract infections including streptococcal pharyngitis and  tonsillitis
  • Acute otitis media and acute maxillary sinusitis
  • Lower respiratory tract infections including atypical pneumonia, bronchitis
  • Skin and skin structure infections including impetigo, folliculitis, cellulitis, abscesses (abscesses usually require surgical drainage)
  • Disseminated or localized mycobacterial infections due to Mycobacteriumintracellulare or Mycobacterium avium. Localized infections due to Mycobacteriumkansasii, Mycobacteriumchelonae and Mycobacterium fortuitum(usually in combination with other antimicrobial agents)
  • Helicobacter pylori infections (in combination with other drugs)
  • Odontogenic infections


Usual Recommended Oral Adult Dose:

Serious Infections: 150 mg to 300 mg every 6 hours

More Severe Infections: 300 mg to 450 mg every 6 hours

Or, as prescribed by a physician.

Recommended Oral Adult Dose for Specific Infections:

Infection Recommended

Oral Clindamycin Dose

Duration of Treatment
Acne 150 mg every 12 hours
Bacterial vaginosis 300 mg every 12 hours 7 days
Cervicitis due to Chlamydia trachomatis 450 mg every 6 hours 10 to 14 days


Pelvic Inflammatory Disease (Inpatient Treatment)

Initially with intravenous (IV) therapy         (Clindamycin IV 900 mg every 8 hours plusan IV antibiotic with an appropriate Gram-negative aerobic spectrum) for at least 4 days and at least 48 hours after the patient improves.

Then continue with oral clindamycin hydrochloride 450 mg every 6 hours to complete duration of treatment.

10 to 14 days
Prevention of Bacterial Endocarditis in penicillin-allergic patients 600 mg, one (1) hour before

the procedure

 single dose
 Pneumocystis jiroveci (carinii) pneumonia in patients with AIDS* 300 mg to 450 mg

every 6 hours





21 days


Note: If the patient should develop serious hematologic adverse effects, the dosage regimen of primaquine and/or clindamycin should be reduced.


Alternative treatment of multi-drug resistant Plasmodium falciparum infection**

20 mg/kg/day divided in

three (3) equal doses




Quinine or Amodiaquine



At least 5 days

Or, as prescribed by a physician.


  • Hypersensitivity to Clindamycin or any ingredient in the product

(Precautions)Not for the treatment of nonbacterial infections & meningitis. Clostridium difficile-associated diarrhea (CDAD). Atopic individuals as well as history of GI disease particularly colitis. Concurrent use w/ neuromuscular blocking agents. G6PD deficiency. Perform blood exam during therapy w/ primaquine & surgical drainage & necrotic tissue removal in combination w/ antibiotic therapy. Severe renal &/or hepatic impairment accompanied by severe metabolic aberrations. Monitor serum levels for high-dose therapy. Periodic blood counts, liver & kidney function tests during prolonged therapy. Increased risk of antibiotic resistance. Overgrowth of nonsusceptible organisms including fungi; liver function tests abnormalities. Pregnancy & lactation. Childn ≤16 yr. Elderly >60 yr.
(Adverse Reactions) GI disturbances, allergic reactions, genital & anal pruritus, genital moniliasis, vaginitis & vag discharge, dizziness, fatigue, headache, agitation, confusion, hallucination, arthralgia, arthritis & joint disorders. Hematological disorders, reversible interstitial nephritis.

SRP: 37.75


Disclaimer: The contents of this site are for information purposes only and should not be construed as a susbtitute for professional medical advice. For diagnosis, treatment and prescription, consult your physician and other healthcare providers. Carefully read all product labels and packaging prior to use.


There are no reviews yet.

Be the first to review “CLINDAMYCIN HCL Ritemed 300 milligrams”

Your email address will not be published. Required fields are marked *